Results 11 to 20 of about 258,291 (316)

Glioblastomas [PDF]

Cancers, 2021
Years ago, glioblastoma lost its second name, multiforme, which possibly was an unfortunate decision given the extraordinary heterogeneity of this overly aggressive primary brain tumor, as effectively exemplified by this Latin adjective [...]
Finocchiaro G., Berzero G.
openaire   +2 more sources

Novel Treatment Strategies for Glioblastoma [PDF]

, 2021
This book is a compilation of articles that brings together current knowledge from an international team of contributors who are dedicated investigators exploring novel strategies for the treatment of glioblastoma.

core   +4 more sources

The role of TGFb/SMAD signaling in glioblastoma [PDF]

Folia Neuropathologica
Glioblastoma is a multifaceted and therapeutically challenging disease. Despite decades of ground-breaking research work, therapeutic options for the cure of glioblastoma are limited.
Gulnara Kapanova, Aigul Tulebayeva, Aigul Bazarbayeva, Assiya Turgambayeva, Aida Akhenbekova, Akmaral Abdykulova, Almat Kodasbayev, Aima Adylova   +7 more
doaj   +2 more sources

Glioblastoma and MiRNAs [PDF]

Cancers, 2021
Glioblastoma (GB) is one of the most common types of lethal brain tumors. Although several treatment options are available including surgery, along with adjuvant chemo and radiotherapy, the disease has a poor prognosis and patients generally die within 14 months of diagnosis. GB is chemo and radio resistant.
Swalih P. Ahmed, Javier S. Castresana, Mehdi H. Shahi   +2 more
openaire   +3 more sources

Non-operable glioblastoma: Proposition of patient-specific forecasting by image-informed poromechanical model [PDF]

, 2023
Work funding with a grant fromLuxembourg National Research Fund (FNR) grant number INTER/ANR/21/16399490 and from Réseau Santé des Arts et Métiers.We propose a novel image-informed glioblastoma mathematical model within a reactive multiphase ...
ROHAN, Pierre-Yves, Davide Baroli, URCUN, Stéphane, Wafa Skalli, Giuseppe Sciumè, BORDAS, Stéphane Pierre Alain, Stéphane P.A. Bordas, SKALLI, Wafa, Stéphane Urcun, SCIUME, Giuseppe, LUBRANO, Vincent, BAROLI, Davide, Bordas, Stéphane, P A, Vincent Lubrano, Pierre-Yves Rohan   +14 more
core   +1 more source

Ferritin in glioblastoma

British Journal of Cancer, 2020
AbstractElevated levels of serum ferritin (SF) are observed in several types of cancer; however, little is known on the association between ferritin and glioma, the most frequent type of human primary brain tumour. Here we report that GBM patients show significantly increased pre-surgical SF levels (i.e. ferritinaemia) within the SF reference range and
Jaksch-Bogensperger, Heidi, Spiegl-Kreinecker, Sabine, Arosio, Paolo, Eckl, Peter, Golaszewski, Stefan, Ebner, Yvonne, Al-Schameri, Rahman, Strasser, Peter, Weis, Serge, Bresgen, Nikolaus   +9 more
openaire   +2 more sources

Alkaloids of fascaplysin are promising chemotherapeutic agents for the treatment of glioblastoma: Review [PDF]

, 2020
Glioblastoma is one of the most aggressive human brain tumors. Even following all the modern protocols of complex treatment, the median patient survival typically does not exceed 15 months.
Valeriia Gulaia, Piatkova, Mariia,, Khotimchenko, Rodion,, Sharma, Aruna,, Mikhail Shmelev, Gulaia, Valeriia,, Bryukhovetskiy, Igor,, Andrey Bryukhovetskiy, Lyakhova, Irina,, Rodion Khotimchenko, Mariia Piatkova, Hari Shanker Sharma, Romanishin, Aleksandr,, Aruna Sharma, Igor Bryukhovetskiy, Bryukhovetskiy, Andrey,, Irina Lyakhova, Aleksandr Romanishin, Shmelev, Mikhail,, Sharma, Hari Shanker,   +19 more
core   +1 more source

Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities [PDF]

, 2011
High grade gliomas, including anaplastic glioma WHO grade III and glioblastoma WHO IV (GBM), carry a dismal prognosis. Taking all nowadays-available therapeutics options, including radiation, chemotherapy and surgery, for GBM into consideration the ...
Siegelin, Yasemin, Siegelin Yasemi, Siegelin, Markus David, Siegelin Markus David, Siegelin Yasemin, Siegelin Markus   +5 more
core   +1 more source

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

Frontiers in Oncology, 2020
Introduction: O6-methylguanine-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase (IDH) mutation status are important prognostic factors for patients with glioblastoma.
Fatih Incekara, Fatih Incekara, Sebastian R. van der Voort, Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Rishi Nandoe Tewarie, Geert Lycklama, Arnaud J. P. E. Vincent, Johan M. Kros, Stefan Klein, Martin van den Bent, Marion Smits   +11 more
doaj   +1 more source

Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy [PDF]

, 2009
Background: Glioblastoma is the most frequent and most malignant primary brain tumor with a poor prognosis. The translation of therapeutic strategies for glioblastoma from the experimental phase into the clinic has been limited by insufficient animal ...
Oleg Tsinkalovsky, Euskirchen Philipp, Tsanan Giroglou, Huszthy, Peter C., Giroglou Tsanan, Skaftnesmo, Kai Ove, Miletic, Hrvoje, Miletic Hrvoje, Peter C Huszthy, Kai Ove Skaftnesmo, Tsinkalovsky Oleg, von Laer Dorothee, Euskirchen, Philipp, Dorothee von Laer, Hrvoje Miletic, Laer, Dorothee von, Rolf Bjerkvig, Giroglou, Tsanan, Tsinkalovsky, Oleg, Huszthy Peter C., Skaftnesmo Kai Ove, Bjerkvig Rolf, Philipp Euskirchen, Bjerkvig, Rolf   +23 more
core   +1 more source